Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Toolkit
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Toolkit
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Hematology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Shorter Telomeres Linked to Dangerous Blood Cell Mutations
September 2025
A major UK-based study has revealed a new link between ageing, DNA changes and the development of blood cancers….
Read more
22 Jul 2025
ICML 2025: Combining Radiation and Bispecific Antibodies in Blood Cancer
A new study presented at the 2025 International Conference on Malignant Lymphoma (ICML) has shown that radiation therapy can be safely integrated with bispecific antibody treatment in patients with relapsed or refractory blood cancers…
22 Jul 2025
ICML 2025: Blood Test Shows Promise for Tracking Lymphoma Relapse Risk
Real-world data presented at the 2025 International Conference on Malignant Lymphoma (ICML) has provided new insights into the use of clonoSEQ, a circulating tumour DNA (ctDNA) assay…
21 Jul 2025
ICML 2025: Regional and Socioeconomic Disparities in CNS Lymphoma Outcomes
A large-scale national study of primary central nervous system lymphoma (PCNSL) in England has revealed stark differences in incidence and survival based on geography, age, and deprivation…
20 Jul 2025
ICML 2025: Bridging Radiotherapy May Reduce CAR-T-Related Toxicity
Bridging radiotherapy (BRT) before CAR-T cell therapy may help reduce severe treatment-related toxicities in patients with B-cell lymphoma…
17 Jul 2025
Physical Function Scores Help Predict Outcomes in Multiple Myeloma Treatment
A new study finds that how patients feel and function before starting treatment can help predict how well they’ll respond to multiple myeloma therapies.
16 Jul 2025
New Genetic Score May Guide Leukaemia Treatment
A large new study has confirmed the clinical relevance of a pharmacogenomic score that could help tailor leukaemia treatment and address persistent racial disparities in outcomes.
15 Jul 2025
Scientists Discover Potent New Anticancer Compounds from Fungi
In a breakthrough that could lead to powerful new cancer treatments, researchers have identified a novel class of fungal compounds with potent anticancer properties.
5 Jul 2025
New Therapeutic Targets Identified in Childhood Acute Myeloid Leukaemia
A recent study has revealed promising targets for treating childhood acute myeloid leukaemia….
Loading posts...
« Previous
1
2
3
4
5
…
39
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View